Schedule 13G ownership disclosure

STEMLINE THERAPEUTICS INC

Security class unavailable · CUSIP: 85858C107

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,059,393
Percent of class
3.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-19-000749
Form type
SC 13G/A
Filer
Consonance Capital Management LP
CIK
CIK 1544773
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub